Early Tumor Marker Response Predicts Treatment Outcomes in Patients with Unresectable Hepatocellular Carcinoma Receiving Combined Lenvatinib, Immune Checkpoint Inhibitors, and Transcatheter Arterial Chemoembolization Therapy

Meng-Chao Luo,1,2,* Jia-Yi Wu,1,3,* Jun-Yi Wu,1,3 Zhong-Tai Lin,1,2 Yi-Nan Li,3 Zhen-Xin Zeng,3 Shao-Ming Wei,1,2 Mao-Lin Yan1,3 1Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian Province, 350001, People’s Republic of China; 2Department of General Surgery, Fujian...

Полное описание

Библиографические подробности

Главные авторы:	Luo MC, Wu JY, Lin ZT, Li YN, Zeng ZX, Wei SM, Yan ML
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Dove Medical Press 2023-10-01
Серии:	Journal of Hepatocellular Carcinoma
Предметы:	unresectable hepatocellular carcinoma alpha-fetoprotein des-gamma-carboxyprothrombin combination therapy tumor response
Online-ссылка:	https://www.dovepress.com/early-tumor-marker-response-predicts-treatment-outcomes-in-patients-wi-peer-reviewed-fulltext-article-JHC
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!